Artrya (ASX:AYA) is changing how the world diagnoses, and therefore treats, coronary artery disease. We are doing it in a way that is better for patients, healthcare professionals and health systems. Artrya’s software-as-a-medical-device, Salix Coronary Anatomy, is an AI-based diagnostic support solution that quickly analyzes cardiac CT scans to assist clinicians in accurately determining the presence and extent of calcified and non-calcified atherosclerotic plaque and high-risk plaque features. We partner with healthcare delivery systems to help implement new cardiac care models that can rule out (or in) coronary artery disease at speed, for patients presenting with chest pain.